automatiqc

Innovative cloud-based application to aid in quick and efficient document authoring  

Automatiqc, an AI tool designed to improve quality and bring efficiencies to the medical and regulatory writing process

Automatiqc

automatiqc mms holdings logo png medical writing medical writer services resource outsource vendor strategy technology solutions services Automatiqc is a cloud-based solution that utilizes robotic process automation (RPA), a form of artificial intelligence (AI), to apply the necessary document formatting and style conventions. This frees up writers to focus on the key messaging, stakeholder alignment, and other key elements that are most critical to the medical and regulatory writing process.   

Demonstrated time savings have provided sponsors up to one-third (33 percent) of time back in the quality process, with efficiencies across several roles.  

Additional key benefits of Automatiqc include: 

  • Removes the burden of style and formatting from the regulatory or medical writer, saving time for critical data elements  
  • Built-in set of rules that can be customized to meet any internal company or external audience document style requirements 
  • Compounding efficiencies with document amendments, improving the quality of documents and elimination of the review and QC steps in subsequent drafts or document amendments 
  • Complementary and compatible with other tools including PleaseReview, Veeva RIM, and many others 
  • Easy output provided in tracked changes for greater visibility to the writer  

With this innovative medical writing technology, Automatiqc users are now able to focus where they can bring the greatest value – to the science of Medical & Regulatory Writing 

 

Fill out the form at right to request a demo of Automatiqc 

Find out more about our commitment to innovation and tech-enablement here

Authoring Efficiencies Webinar

expert insights

rare diseases drug development draft guidance US Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, and other global health authorities service provider vendor services cro consultant clinical research organization mms holdings orphan regulations regulatory submissions medical writing QC as a service automatiqc

Medical writing experts discuss recent technological advancements, writing efficiencies, and a top-to-bottom integration approach across key stakeholders to produce high-quality CSRs that are FDA/EMA submission- and clinical trial disclosure-ready.

Watch the webinar

Request a demo of Automatiqc

12 + 14 =

Regulatory Affairs
& Operations

Data Management
& Biostatistics

Regulatory
& Medical Writing

Drug Safety
& Pharmacovigilance

Compliance
& Transparency

 

6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

Email Us

LinkedIn

 

Facebook

Learn more about working with MMS

9 + 15 =

© MMS Holdings Inc. All rights reserved. Privacy Policy